Jason Shand Robins insider trades
Open-market stock purchases and sales by Jason Shand Robins, Chief Financial Officer at Ocular Therapeutix, Inc, from SEC Form 4 filings since Jan 20, 2026.
Companies traded
- OCUL Ocular Therapeutix, Inc: other filings, last Jun 10, 2026